PEOPLE ON THE MOVE
Myoderm's new COO is James Lovett
Myoderm Inc. has hired a new Chief Operating Officer (COO), James Lovett.
Pennsylvania, US-based Myoderm is a specialist in global clinical trial supply, with deep expertise in sourcing, management, and labelling of commercial drugs and supplies.
James previously spent 14 years working for Covance Inc., and before that worked at FMC Corp. In this new role he will work alongside long-time Managing Director Michael Cohen.
James has also played leadership roles in the Association of Clinical Research Organizations and National Association for Biomedical Research.